Familial Mediterranean fever type 2 with heterozygous mutations of E148Q and M694I in a Japanese patient with progressive systemic AA amyloidosis^*

References

• Sohar E, Gafni J, Pras M, et al. Familial Mediterranean fever. A survey of 470 cases and review of the literature. Am J Med. 1967;43:227–253.
   PubMed Web of Science ®Google Scholar
• Schwabe AD, Peters RS. Familial Mediterranean fever in Armenians. Analysis of 100 cases. Medicine (Baltimore). 1974;53:453–462.
   PubMed Web of Science ®Google Scholar
• Rogers DB, Shohat M, Petersen GM, et al . Familial Mediterranean fever in Armenians: autosomal recessive inheritance with high gene frequency. Am J Med Genet. 1989;34:168–172.
   Web of Science ®Google Scholar
• Livneh A, Langevitz P, Zemer D, et al. Criteria for the diagnosis of familial Mediterranean fever. Arthritis Rheum. 1997;40:1879–1885.
   PubMed Web of Science ®Google Scholar
• Sarı İ, Birlik M, Kasifoğlu T. Familial Mediterranean fever: an updated review. Eur J Rheumatol. 2014;1:21–33.
   PubMedGoogle Scholar
• Tunca M, Akar S, Onen F. Turkish FMF Study Group. Familial Mediterranean fever (FMF) in Turkey: results of a nationwide multicenter study. Medicine. 2005;84:1–11.
   PubMed Web of Science ®Google Scholar
• Altunoğlu A, Erten Ş, Canoz MB, et al. Phenotype 2 familial Mediterranean fever: evaluation of 22 case series and review of the literature on phenotype 2 FMF. Ren Fail. 2013;35:226–230.
   PubMed Web of Science ®Google Scholar
• Touitou I. Infevers: an online database for autoinflammatory mutations. 2001–2018. [cited 2018 May 30] Available from: http://fmf.igh.cnrs.fr/ISSAID/infevers/.
   Google Scholar
• Hurwich BJ, Schwartz J, Goldfarb S. Record survival of siblings with familial Mediterranean fever, phenotype 1 and 2. Arch Intern Med. 1970;125:308–311.
   Google Scholar
• Soriano A, Manna R. Familial Mediterranean fever: new phenotypes. Autoimmun Rev. 2012;12:31–37.
   PubMed Web of Science ®Google Scholar
• Kutlay S, Yilmaz E, Koytak ES, et al. A case of familial Mediterranean fever with amyloidosis as the first manifestation. Am J Kidney Dis. 2001;38:E34.
   Web of Science ®Google Scholar
• Blum A, Gafni J, Sohar E, et al. Amyloidosis as the sole manifestation of familial Mediterranean fever (FMF). Further evidence of its genetic nature. Ann Intern Med. 1962;57:795–799.
   PubMed Web of Science ®Google Scholar
• Konstantopoulos K, Kanta A, Tzoulianos M, et al. Familial Mediterranean fever phenotype II in Greece. Isr Med Assoc J. 2001;3:862–863.
   Web of Science ®Google Scholar
• Livneh A, Langevitz P, Shinar Y, et al. MEFV mutation analysis in patients suffering from amyloidosis of familial Mediterranean fever. Amyloid. 1999;6:1–6.
   PubMed Web of Science ®Google Scholar
• Lachmann HJ, Goodman HJB, Gilbertson JA, et al. Natural history and outcome in systemic AA amyloidosis. N Engl J Med. 2007;356:2361–2371.
   PubMed Web of Science ®Google Scholar
• Kinoshita T, Wang Y, Hasegawa M, et al. PYPAF3, a PYRIN-containing APAF-1-like protein, is a feedback regulator of caspase-1-dependent interleukin-1beta secretion. J Biol Chem. 2005;280:21720–21725.
   PubMed Web of Science ®Google Scholar
• Lich JD, Ting JP. Monarch-1/PYPAF7 and other CATERPILLER (CLR, NOD, NLR) proteins with negative regulatory functions. Microbes Infect. 2007;9:672–676.
   Web of Science ®Google Scholar
• Chae JJ, Wood G, Masters SL, et al. The B30.2 domain of pyrin, the familial Mediterranean fever protein, interacts directly with caspase-1 to modulate IL-1beta production. Proc Natl Acad Sci USA. 2006;103:9982–9987.
   PubMed Web of Science ®Google Scholar
• Touitou I. The spectrum of familial Mediterranean fever (FMF) mutations. Eur J Hum Genet. 2001;9:473–483.
   PubMed Web of Science ®Google Scholar
• Beheshtian M, Izadi N, Kriegshauser G, et al. Prevalence of common MEFV mutations and carrier frequencies in a large cohort of Iranian populations. J Genet. 2016;95:667–674.
   Web of Science ®Google Scholar
• Migita K, Nakamura T, Maeda Y, et al. MEFV mutations in Japanese rheumatoid arthritis patients. Clin Exp Rheumatol. 2008;26:1091–1094.
   PubMed Web of Science ®Google Scholar
• Tsuchiya-Suzuki A, Yazaki M, Nakamura A, et al. Clinical and genetic features of familial Mediterranean fever in Japan. J Rheumatol. 2009;36:1671–1676.
   PubMed Web of Science ®Google Scholar
• Migita K, Izumi Y, Jiuchi Y, et al. Familial Mediterranean fever is no longer a rare disease in Japan. Arthritis Res Ther. 2016;18:175.
   PubMed Web of Science ®Google Scholar
• Tchernitchko D, Legendre M, Cazeneuve C, et al. The E148Q MEFV allele is not implicated in the development of familial Mediterranean fever. Hum Mutat. 2003;22:339–340.
   PubMedGoogle Scholar
• Tchernitchko D, Moutereau S, Legendre M, et al. MEFV analysis is of particularly weak diagnostic value for recurrent fevers in Western European Caucasian patients. Arthritis Rheum. 2005;52:3603–3605.
   PubMed Web of Science ®Google Scholar
• Migita K, Agematsu K, Yazaki M, et al. Familial Mediterranean fever: genotype-phenotype correlations in Japanese patients. Medicine (Baltimore). 2014;93:158–164.
   PubMed Web of Science ®Google Scholar
• Shohat M, Magal N, Shohat T, et al. Phenotype–genotype correlation in familial Mediterranean fever: evidence for an association between Met694Val and amyloidosis. Eur J Hum Genet. 1999;7:287–292.
   PubMed Web of Science ®Google Scholar
• Killic A, Varkal MA, Durmus MS, et al. Relationship between clinical findings and genetic mutations in patients with familial Mediterranean fever. Ped Rheumatol. 2015;13:59.
   Web of Science ®Google Scholar
• Nursal AF, Tekcan A, Kaya SU, et al. Mutational spectrum of the MEFV gene in AA amyloidosis associated with familial Mediterranean fever. Iran J Kidney Dis. 2016;10:107–112.
   Web of Science ®Google Scholar
• Booth DR, Booth SE, Gillmore JD, et al. SAA1 alleles as risk factors in reactive systemic AA amyloidosis. Amyloid. 1998;5:262–265.
   PubMed Web of Science ®Google Scholar
• Moriguchi M, Terai C, Koseki Y, et al. Influence of genotypes at SAA1 and SAA2 loci on the development and the length of latent period of secondary AA-amyloidosis in patients with rheumatoid arthritis. Hum Genet. 1999;105:360–366.
   PubMed Web of Science ®Google Scholar
• Nakamura T, Higashi S, Tomoda K, et al. Significance of SAA1.3 allele genotype in Japanese patients with amyloidosis secondary to rheumatoid arthritis. Rheumatology (Oxford). 2006;45:43–49.
   PubMed Web of Science ®Google Scholar
• Atoyan S, Hayrapetyan H, Sarkisian T, et al. MEFV and SAA1 genotype associations with clinical features of familial Mediterranean fever and amyloidosis in Armenia. Clin Exp Rheumatol. 2016;34:72–76.
   Web of Science ®Google Scholar
• Turkcapar N, Tuncali T, Kutlay S, et al. The contribution of genotypes at the MICA gene triplet repeat polymorphisms and MEFV mutations to amyloidosis and course of the disease in the patients with familial Mediterranean fever. Rheumatol Int. 2007;27:545–551.
   Web of Science ®Google Scholar
• Tabarean IV, Behrens MM, Bartfai T, et al. Prostaglandin E2-increased thermosensitivity of anterior hypothalamic neurons is associated with depressed inhibition. Proc Natl Acad Sci USA. 2004;101:2590–2595.
   Web of Science ®Google Scholar